News brief­ing: Pre­ci­sion Med­i­cine Group ac­quires cell and gene ther­a­py-fo­cused ser­vices firm Project Far­ma; Roost­er­Bio and Sar­to­rius col­lab on gene ther­a­py man­u­fac­tur­ing

As more and more play­ers pur­sue cell and gene ther­a­pies, com­pa­nies are look­ing for ways to keep up on the man­u­fac­tur­ing end.

On Thurs­day, Pre­ci­sion Med­i­cine Group took the wraps off a deal to buy out Project Far­ma, a bio­engi­neer­ing ser­vices firm that sup­ports the man­u­fac­tur­ing and scale-up of cell and gene ther­a­pies. Project Far­ma will join Pre­ci­sion for Med­i­cine, PMG’s re­search and de­vel­op­ment ser­vices arm.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER